NCT02699554

Brief Summary

Impaired neuromuscular control hinders movement for individuals with cerebral palsy and other neurological disorders. In this research, the investigators are developing new tools to quantify impaired neuromuscular control in cerebral palsy and evaluate changes after one of the most common treatments, orthopaedic surgery. The results from this research will empower clinicians to identify patient-specific factors that contribute to impaired movement and improve treatment and quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 20, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 4, 2016

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

May 9, 2022

Completed
Last Updated

May 9, 2022

Status Verified

May 1, 2022

Enrollment Period

5 years

First QC Date

January 20, 2016

Results QC Date

March 15, 2022

Last Update Submit

May 5, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Walk Dynamic Motor Control Index 6-months After Orthopaedic Surgery

    The Walk Dynamic Motor Control Index (Walk DMC) is a specific measurement calculated from electromyography during gait using nonnegative matrix factorization. A value of 100 indicates complexity of neuromuscular control similar to typically-developing peers and each 10 point deviation represents one standard deviation from typically-developing peers. Thus, a value of 80 would indicate that an individual's muscle coordination during gait is two standard deviations below the complexity of unimpaired individuals.

    6-months after individual's orthopaedic surgery

  • Change in Walk Dynamic Motor Control Index 1-year After Orthopaedic Surgery

    The Walk Dynamic Motor Control Index (Walk DMC) is a specific measurement calculated from electromyography during gait using nonnegative matrix factorization. A value of 100 indicates complexity of neuromuscular control similar to typically-developing peers and each 10 point deviation represents one standard deviation from typically-developing peers. Thus, a value of 80 would indicate that an individual's muscle coordination during gait is two standard deviations below the complexity of unimpaired individuals.

    1-year after individual's orthopaedic surgery

Secondary Outcomes (2)

  • Change in Gait Deviation Index 6-months After Orthopaedic Surgery

    6-months after individual's orthopaedic surgery

  • Change in Gait Deviation Index 1-year After Orthopaedic Surgery

    1-year after individual's orthopaedic surgery

Study Arms (1)

Orthopaedic surgery

Procedure: Single-event multilevel surgery

Interventions

Orthopaedic surgery

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Individuals with cerebral palsy, diplegia subtype, with mild or moderate impairment, Gross Motor Function Classification System (GMFCS) Levels I-III, between the ages of 6 - 18.

You may qualify if:

  • Diplegic cerebral palsy
  • Mild or Moderate Impairment, Gross Motor Function Classification System (GMFCS) Levels I-III
  • Will receive follow-up care and physical therapy within the Gillette Children's Specialty Healthcare system

You may not qualify if:

  • Botulinum toxin injections, baclofen, or other similar treatments in the 3 months prior to pre-operative gait analysis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gillette Children's Specialty Healthcare

Saint Paul, Minnesota, 55101, United States

Location

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Limitations and Caveats

This was a prospective observational cohort study, not a randomized controlled trial. 32 of the 55 participants returned for the 6-month post-operative gait analysis and 46 of the 55 participants returned for the 12-month post-operative gait analysis.

Results Point of Contact

Title
Katherine Steele
Organization
University of Washington

Study Officials

  • Katherine M Steele, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Mechanical Engineering

Study Record Dates

First Submitted

January 20, 2016

First Posted

March 4, 2016

Study Start

September 1, 2015

Primary Completion

September 1, 2020

Study Completion

September 1, 2020

Last Updated

May 9, 2022

Results First Posted

May 9, 2022

Record last verified: 2022-05

Locations